DZ Bank Put 2.374 MDGD 20.09.2024/ DE000DQ1YXU4 /

24/04/2024 13:08:39	Chg.+0.110	Bid21:58:07	Ask-	Underlying	Strike price	Expiration date	Option type
0.870EUR	+14.47%	- Bid Size: -	- Ask Size: -	MEDIGENE AG NA O.N.	2.374 -	20/09/2024	Put

GlobeNewswire 21/05 Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...

GlobeNewswire 15/05 Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS

GlobeNewswire 14/05 Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise

GlobeNewswire 07/05 Medigene to Present at Upcoming Conferences

GlobeNewswire 06/05 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...

GlobeNewswire 02/05 Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell R...

GlobeNewswire 02/05 Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein

GlobeNewswire 26/04 Medigene AG reports Financial Results and Business Update for Q1 2024

GlobeNewswire 25/04 Medigene presents streamlined 6-day, high stemness TCR-T therapy production process

GlobeNewswire 17/04 Medigene to Present at Upcoming Scientific Conferences

GlobeNewswire 08/04 Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR ...

GlobeNewswire 04/04 Medigene AG Secures European Patent for its iM-TCR Technology

GlobeNewswire 28/03 Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire 19/03 Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

GlobeNewswire 18/03 Medigene AG to report full year 2023 financial results on March 28, 2024

GlobeNewswire 06/03 Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Pr...

GlobeNewswire 04/03 Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety...

GlobeNewswire 29/02 Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentia...

GlobeNewswire 19/02 Medigene to Present at Upcoming Conferences

GlobeNewswire 12/02 Medigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR...

GlobeNewswire 19/12/2023 Medigene AG to attend at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire 21/11/2023 Medigene AG Announces Prioritization of Pipeline and Resource Allocation as well as Extension of Cas...

GlobeNewswire 21/11/2023 Medigene amends 2023 financial guidance

GlobeNewswire 04/11/2023 Medigene presents new data for MDG2011, the first TCR in a novel KRAS library, demonstrating capabil...

GlobeNewswire 26/10/2023 Medigene Reports Financial Results and Corporate Update for Q3 2023